Difficulty: Medium
Average Score: 92%
Practice
A decrease in which of the following neurotransmitters has been implicated in depression?
Correct answer
B
Rationale
In the context of family-centered care in nursing, understanding the role of neurotransmitters in mental health conditions like depression is crucial for providing holistic care to patients and their families. The correct answer is option B) Norepinephrine, serotonin, and dopamine.
Norepinephrine, serotonin, and dopamine are known as monoamine neurotransmitters and play key roles in regulating mood, emotions, and cognitive functions. A decrease in these neurotransmitters has been linked to the development of depression. Norepinephrine is involved in the body's stress response, serotonin regulates mood and social behavior, and dopamine is associated with pleasure and reward pathways in the brain.
Option A includes GABA, acetylcholine, and aspartate, which are not primarily implicated in depression. GABA is an inhibitory neurotransmitter, acetylcholine is involved in muscle movement and memory, and aspartate is an excitatory neurotransmitter.
Option C includes somatostatin, substance P, and glycine, which are not typically associated with depression but rather with pain modulation, sensory processing, and inhibitory functions in the nervous system.
Option D includes glutamate, histamine, and opioid peptides, which play roles in various physiological processes but are not the primary neurotransmitters implicated in depression.
By understanding the role of neurotransmitters in depression, nurses can better assess, support, and educate patients and families about the importance of medication adherence, lifestyle modifications, and therapy in managing depression. This knowledge enhances the quality of care provided in a family-centered approach, promoting better outcomes and overall well-being for patients.
Norepinephrine, serotonin, and dopamine are known as monoamine neurotransmitters and play key roles in regulating mood, emotions, and cognitive functions. A decrease in these neurotransmitters has been linked to the development of depression. Norepinephrine is involved in the body's stress response, serotonin regulates mood and social behavior, and dopamine is associated with pleasure and reward pathways in the brain.
Option A includes GABA, acetylcholine, and aspartate, which are not primarily implicated in depression. GABA is an inhibitory neurotransmitter, acetylcholine is involved in muscle movement and memory, and aspartate is an excitatory neurotransmitter.
Option C includes somatostatin, substance P, and glycine, which are not typically associated with depression but rather with pain modulation, sensory processing, and inhibitory functions in the nervous system.
Option D includes glutamate, histamine, and opioid peptides, which play roles in various physiological processes but are not the primary neurotransmitters implicated in depression.
By understanding the role of neurotransmitters in depression, nurses can better assess, support, and educate patients and families about the importance of medication adherence, lifestyle modifications, and therapy in managing depression. This knowledge enhances the quality of care provided in a family-centered approach, promoting better outcomes and overall well-being for patients.